glp 1 mounjaro for weight loss Is the Same as Ozempic FDA approves new version of

A 2024 review published in Nature Medicine highlights the growing role of GLP-1 receptor agonists in obesity treatment and long-term disease prevention Similarly, updated findings in JAMA (2024) reinforce their effectiveness for sustained weight loss when used as part of a comprehensive care plan

Ulus Travma Acids Cerrahi Derg 30 , 229235 (2024)

Reports 18 LiJ.PeiM

It also increases GH release from the hypothalamus by stimulating GHRH neurons and suppressing somatostatin tone, creating a multi-level amplification of the GH axis

Because the article frames this as an absence of data rather than a finding of safety or harm, which is exactly why caution is the default

(2026, April 6)